Scancell Holdings plc

84.00pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:SCLPHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (5.65%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 0.74
PE TTM —
TSR TTM (14.72%)
Mkt cap £101.8M
ROIC (215.54%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
105p
25.16%
(69.41%)
Hold 12|6|11|11|11
2Q26
3Q26
4Q26
1Q27
Earnings per share£
2.11
2.01
2.10
2.06
27.86%
10.57%
13.26%
(0.30%)
Revenue£M
5.729
5.715
5.709
5.643
11.18%
10.92%
8.90%
2.61%
Peers (US$137.0M)
Cap (US$)
PE
137.1M
13.58x
110.0M
—
Capital
TTM
5Y
10Y
Leveragex
1.142
0.876
0.759
EBIT/Intx
2.615
0.210
0.170
Own earn%
33.56
151.89
116.63
Sh yield%
35.81
30.68
29.87
Owners
Insiders/Inst%
11.04
64.26
Short interest%
5.91
SBC / revenue%
4.19
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
14–21
$1 testx
—
Incr. ROIC%
6